March 28 ICOC/ARS Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020

Date: March 28, 2024
Time: 9:00 am to 4:00 pm
Location: Hyatt Regency San Francisco Airport, Cypress Room BC
1333 Old Bayshore Hwy
Burlingame, CA 94010

Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following: 

• Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment.
• Once we call your name you may have up to 3 Minutes (depending on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.
• Written comment may be sent to the following email address: cmandac@cirm.ca.gov
• Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.

 

YouTube:
https://www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 820 8697 6171
Passcode: 240328

 

Open Session

1. Call to Order
2. Roll Call
3. Chair’s Report
4. Vice-Chair’s Report
5. Interim President’s Report
   • Presentation: Strategic Allocation Framework
   • Supporting Materials: Strategic Allocation Framework
   • Presentation: COMPASS Program

Consent Calendar

6. Consideration of Minutes from February 22 ICOC/ARS Meeting
7. Consideration of Appointment of Scientific Members to the Grants Working Group
8. Consideration of Appointment of a Member to the Accessibility & Affordability Working Group POSTPONED
9. Approval of Requests to Attend Remotely (Gov’t Code Section 11123.2(j))

Open Session

10. Consideration of ICOC Chair/Vice-chair Review: Procedures, Job Descriptions, and Survey Questions
    • Chair Job Description
    • Vice-chair Job Description
    • Chair Survey Questions
    • Vice-chair Survey Questions
    • Overview and Timeline
11. Consideration of the President & CEO Job Description
12. Discussion of Board Chair’s Plan for Onboarding New President & CEO
13. Consideration of Applications Submitted in Response to Infrastructure Program Announcements (INFR7)
    • Presentation
    • Summaries
    • Letter to the Board
14. Consideration of Applications Submitted in Response to Clinical Trial Stage Projects Program Announcements (CLIN 1 or 2)
    • Presentation
    • Summaries
15. Consideration of Applications Submitted in Response to Discovery Program Announcements (DISC0)
    • Presentation
    • Summaries (updated 3/25/24)
    • Letter to the Board
    • Letter to the Board

Closed Session

16. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items 13, 14, and 15. (Health & Safety Code 125290.30(f) (3) (B) and (C)).
17. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to BLA status for CLIN portfolio. (Health & Safety Code 125290.30(f) (3) (B) and (C)).

Open Session

18. Update from Presidential Search Subcommittee
19. Update from Neuro Task Force
20. Update from Science Subcommittee
21. Update from Communications Subcommittee
22. Discussion of Management’s Response to the Performance Audit
23. General Comments on ARS Process
24. Public Comment
    • Letter to the Board
25. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/.

The Committee may take action on any item listed on this agenda.

---